SF-based Foresite Capital's biotech-focused 'blank check' IPO raises $106M
August 12, 2020 at 13:56 PM EDT
The leaders of San Francisco-based Foresite Capital will now try to find a biotech company to help take public with the funds they raised through their special purpose acquisition company, FS Development Corp.
